Hemolysis: Clinical Trials

3 trials for Hemolysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy
ALXN2050 - Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 2TerminatedAlexion Pharmaceuticals, Inc.292019-12-162024-11-20
Study of Albumin to Reduce Inflammation Following Surgery
20% Human albumin solution, Gelofusin - Systemic Inflammatory Response Syndrome, Cardiopulmonary Bypass
Phase 2TerminatedImperial College London2322008-12-012014-05-28
A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
Stannsoporfin, Placebo, PhotoTherapy (as needed) - Hyperbilirubinemia, Neonatal
Phase 2TerminatedInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company582008-08-012019-10-30

Narrower conditions

Hemoglobinuria, Paroxysmal (1)  ·  Hyperbilirubinemia, Neonatal (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Bone Marrow Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hyperbilirubinemia (1)  ·  Infant, Newborn, Diseases (1)  ·  Inflammation (1)  ·  Myelodysplastic Syndromes (1)  ·  Shock (1)

Interventions

Phototherapy (1)  ·  Sodium Chloride (1)  ·  succinylated gelatin (1)  ·  tin mesoporphyrin (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  Imperial College London (1)  ·  InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1)

Countries

Spain (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Poland (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Mark J Griffiths (1)

Results publications

PMID 41124654

NIH funding

2009 (1), 2019 (1)